Quarterly Results

  • Company Name :
Glaxosmithkline Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500660
  • NSE Symbol:
  • GLAXO
  • P/E(TTM):
  • 46.96
  • ISIN Demat:
  • INE159A01016
  • Div & Yield%:
  • 2.07
  • EPS(TTM):
  • 55.42
  • Book Value(₹):
  • 115.06
  • Market Cap(₹Cr.):
  • 44,091.31
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 973.63 804.83 966.08
Excise Duty 0.00 0.00 0.00
Net Sales 973.63 804.83 966.08
Other Operating Income 0.00 0.00 0.00
Other Income 33.91 43.76 39.46
Total Income 1,007.54 848.59 1,005.54
Total Expenditure 638.95 554.08 635.34
PBIDT 368.59 294.51 370.20
Interest 0.51 0.42 0.58
PBDT 368.08 294.09 369.62
Depreciation 17.43 15.52 14.72
Tax 95.21 73.85 89.34
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.44 0.02 5.42
Reported Profit After Tax 255.00 204.70 260.14
Extra-ordinary Items 1.92 0.00 0.00
Adjusted Profit After Extra-ordinary item 253.08 204.70 260.14
EPS (Unit Curr.) 14.92 12.08 15.35
EPS (Adj) (Unit Curr.) 14.92 12.08 15.35
Calculated EPS (Unit Curr.) 15.05 12.08 15.36
Calculated EPS (Adj) (Unit Curr.) 15.05 12.08 15.36
Calculated EPS (Ann.) (Unit Curr.) 60.21 48.33 61.42
Calculated EPS (Adj) (Ann.) (Unit Curr.) 60.21 48.33 61.42
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 169.41 169.41 169.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 37.86 36.59 38.32
PBDTM(%) 37.80 36.54 38.26
PATM(%) 26.19 25.43 26.93